A report of the American College of Cardiology/American Heart Association
Task Force on Clinical Practice Guidelines
CITATION: J Am Coll Cardiol. Nov 2018; DOI: 10.1016/j.jacc.2018.11.003
Scott M. Grundy, MD, PhD, FAHA, Chair
Neil J. Stone, MD, FACC, FAHA, Vice Chair
Alison L. Bailey, MD, FACC, FAACVPR
Craig Beam, CRE
Kim K. Birtcher, MS, PharmD, AACC, FNLA
Roger S. Blumenthal, MD, FACC, FAHA, FNLA
Lynne T. Braun, PhD, CNP, FAHA, FPCNA, FNLA
Sarah de Ferranti, MD, MPH
Joseph Faiella-Tommasino, PhD, PA-C
Daniel E. Forman, MD, FAHA
Ronald Goldberg, MD
Paul A. Heidenreich, MD, MS, FACC, FAHA
Mark A. Hlatky, MD, FACC, FAHA
Daniel W. Jones, MD, FAHA
Donald Lloyd-Jones, MD, SCM, FACC, FAHA
Nuria Lopez-Pajares, MD, MPH
Chiadi E. Ndumele, MD, PhD, FAHA
Carl E. Orringer, MD, FACC, FNLA
Carmen A. Peralta, MD, MAS
Joseph J. Saseen, PharmD, FNLA, FAHA
Sidney C. Smith, Jr, MD, MACC, FAHA
Laurence Sperling, MD, FACC, FAHA, FASPC
Salim S. Virani, MD, PhD, FACC, FAHA
Joseph Yeboah, MD, MS, FACC, FAHA
Writing Committee:
The purpose of the present guideline is to address the practical management of patients with high
blood cholesterol and related disorders. The 2018 Cholesterol Guideline is a full revision of the 2013
ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular
Risk in Adults.
The following resource contains tables and gures from the 2018 Guideline for the Management of
Blood Cholesterol. The resource is only an excerpt from the Guideline and the full publication should
be reviewed for more tables and gures as well as important context.
2018 Guideline on the Management of Blood Cholesterol
GUIDELINES MADE SIMPLE